Tackling Toxicity Studies & Moving Lead Candidates to the Clinic for Myasthenia Gravis

Time: 3:45 pm
day: Conference Day One


  • Highlighting the unique safety risks of the different antigen-specific approaches
  • Discussing the toxicity studies for lead candidates to accelerate to the clinic
  • Showcasing the data from toxicity studies in tolerance for autoimmune diseases
  • Divulging regulatory discussions to illuminate progressing the tolerance landscape and approaches forward